ArticleClinical & experimental metastasis2025

Impact of concomitant use of proton pump inhibitors or cardiovascular medication on survival outcomes of patients with metastatic renal cell carcinoma treated with nivolumab.

Ondřej Fiala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.